InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,312.80
(
2.41%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.32
(
2.68%
)
Bitcoin
62,969.30
(
2.10%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

guardiangel

Send PM Follow Ignore
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

guardiangel

Re: dcspka post# 26363

Saturday, 11/22/2014 10:33:29 PM

Saturday, November 22, 2014 10:33:29 PM

Post# of 30046
This is why we believe provista DX will use Radient shell to go public... imo Wolf

http://www.biocentury.com/products/LymPro_Test

LymPro Test


Company Memory Dx LLC
Description Measure CD69 presentations at the surface in peripheral blood lymphocytes (PBLs) with and without mitogenic stimulation
Molecular Target Not applicable
Mechanism of Action Diagnostic
Therapeutic Modality Diagnostics
Latest Stage of Development Pilot
Standard Indication Neurology, Diagnostic
Indication Details Diagnose chronic traumatic encephalopathy; Diagnose mild to moderate Alzheimer's disease (AD); Diagnose moderate and severe Alzheimer's disease (AD); Early diagnosis of Alzheimer's disease (AD)
Regulatory Designation

Partner

Amarantus BioScience Holdings Inc.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up